US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NYSE
KV Pharmaceutical Co. CL A (KV.A)
KV Pharmaceutical Co. CL A (KV.A) Noticias

KV.A

K V Pharma (KV.A)

KV Pharmaceutical Co. CL A

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:KV.A

1 2 3 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
16/09/2013	09:26	PR Newswire (US)	KV Pharmaceutical Company Completes Reorganization And Successfully Emerges From Chapter 11 With $375 Million Recapitalization	NYSE:KV.A	KV Pharmaceutical Co. CL A
24/01/2013	07:00	PR Newswire (US)	Ther-Rx Corporation and Perrigo Company Announce the Availability of Gynazole-1® (Butoconazole Nitrate Vaginal Cream USP, 2%...	NYSE:KV.A	KV Pharmaceutical Co. CL A
28/12/2012	11:43	PR Newswire (US)	K-V Pharmaceutical Receives Court Approval of Hologic Settlement	NYSE:KV.A	KV Pharmaceutical Co. CL A
12/12/2012	17:39	PR Newswire (US)	K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of P...	NYSE:KV.A	KV Pharmaceutical Co. CL A
10/08/2012	07:00	PR Newswire (US)	K-V Pharmaceutical Use of Cash Collateral Approved by U. S. Bankruptcy Court	NYSE:KV.A	KV Pharmaceutical Co. CL A
08/08/2012	10:09	PR Newswire (US)	K-V Pharmaceutical "First Day" Motions Approved by U.S. Bankruptcy Court	NYSE:KV.A	KV Pharmaceutical Co. CL A
07/08/2012	11:16	PR Newswire (US)	K-V Pharmaceutical Class A and Class B Common Stock Begin Trading on the OTC Markets	NYSE:KV.A	KV Pharmaceutical Co. CL A
06/08/2012	06:57	PR Newswire (US)	K-V Pharmaceutical Announces Planned Transition of Trading of Class A and Class B Common Shares to the OTC Markets	NYSE:KV.A	KV Pharmaceutical Co. CL A
03/08/2012	23:56	PR Newswire (US)	K-V Pharmaceutical Company Files Voluntary Petitions for Reorganization to Restructure Financial Obligations	NYSE:KV.A	KV Pharmaceutical Co. CL A
03/08/2012	10:27	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NYSE:KV.A	KV Pharmaceutical Co. CL A
31/07/2012	16:09	Edgar (US Regulatory)	Securities Registration Statement (S-1)	NYSE:KV.A	KV Pharmaceutical Co. CL A
26/07/2012	15:27	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	NYSE:KV.A	KV Pharmaceutical Co. CL A
20/07/2012	15:05	PR Newswire (US)	K-V Pharmaceutical Company Announces Additional Notification from NYSE Regarding Listing Criteria	NYSE:KV.A	KV Pharmaceutical Co. CL A
13/07/2012	15:43	Edgar (US Regulatory)	Amended Current report filing (8-K/A)	NYSE:KV.A	KV Pharmaceutical Co. CL A
06/07/2012	15:21	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:KV.A	KV Pharmaceutical Co. CL A
02/07/2012	08:15	PR Newswire (US)	FDA Issues Further Guidance About Makena®	NYSE:KV.A	KV Pharmaceutical Co. CL A
29/06/2012	17:51	PR Newswire (US)	K-V Pharmaceutical Company Announces Notification from NYSE Regarding Listing Criteria	NYSE:KV.A	KV Pharmaceutical Co. CL A
18/06/2012	15:36	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (D)	NYSE:KV.A	KV Pharmaceutical Co. CL A
18/06/2012	08:14	PR Newswire (US)	FDA and CMS Issue Important Updates on Makena®	NYSE:KV.A	KV Pharmaceutical Co. CL A
25/05/2012	15:15	PR Newswire (US)	K-V Pharmaceutical Company States That Its Policy is Not to Comment on Unusual Market Activity	NYSE:KV.A	KV Pharmaceutical Co. CL A
16/05/2012	16:46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:KV.A	KV Pharmaceutical Co. CL A
12/04/2012	15:18	PR Newswire (US)	K-V Pharmaceutical Company to Present at Imperial Capital 2012 Healthcare Investor Forum	NYSE:KV.A	KV Pharmaceutical Co. CL A
02/04/2012	08:01	PR Newswire (US)	K-V Pharmaceutical Company to Present at Needham & Company 11th Annual Healthcare Conference	NYSE:KV.A	KV Pharmaceutical Co. CL A
14/02/2012	12:05	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NYSE:KV.A	KV Pharmaceutical Co. CL A
10/02/2012	16:01	Edgar (US Regulatory)	Confidential Treatment Order (CT ORDER)	NYSE:KV.A	KV Pharmaceutical Co. CL A
09/02/2012	15:18	Edgar (US Regulatory)	Quarterly Report (10-Q)	NYSE:KV.A	KV Pharmaceutical Co. CL A
09/02/2012	06:30	PR Newswire (US)	K-V Pharmaceutical Announces Updated Makena® Performance Metrics and Investor Conference Call	NYSE:KV.A	KV Pharmaceutical Co. CL A
26/01/2012	14:30	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	NYSE:KV.A	KV Pharmaceutical Co. CL A
19/12/2011	16:12	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (S-8)	NYSE:KV.A	KV Pharmaceutical Co. CL A
19/12/2011	15:09	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NYSE:KV.A	KV Pharmaceutical Co. CL A

Showing the most relevant articles for your search:NYSE:KV.A

1 2 3 Próxima >

Euro vs US Dollar

JP Morgan Chase

American Express

Deutsche Telekom (QX)

Health Care Select Sector

Energy Select Sector SPDR

BNP Paribas (QX)

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones